Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Pharmacogenet Genomics. 2012 Mar;22(3):219–228. doi: 10.1097/FPC.0b013e32834eb313

Table 1.

Classification of G6PD variants

World Health Organization class Enzyme activity Associated phenotype Variant example Genotyping reference
I Severe deficiency Congenital nonspherocytic hemolytic anemia (CNSHA) Tondela [36]
Palermo [37]
II < 10% severely deficient Risk of acute hemolytic anemia Mediterranean [38]
Canton [39,40]
III 10–60% Moderate deficiency Risk of acute hemolytic anemia A- Haplotype [41,42]
Asahi [42]
IV 60–150% Normal activity No clinical manifestations B (wild type)
A [43]
V > 150% Enhanced activity Hektoen [44,45]

Table based on [22,23,33,34,46] reviews.